D-Index & Metrics Best Publications
Biology and Biochemistry
India
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 65 Citations 13,898 154 World Ranking 4042 National Ranking 8

Research.com Recognitions

Awards & Achievements

2022 - Research.com Biology and Biochemistry in India Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Cancer

The scientist’s investigation covers issues in Cancer research, Signal transduction, Biochemistry, Tissue transglutaminase and Cancer cell. His Cancer research research integrates issues from Cell growth, Small interfering RNA, Focal adhesion, Pathology and Metastasis. His Focal adhesion research focuses on Fibronectin and how it connects with Immunology.

His Signal transduction study combines topics from a wide range of disciplines, such as Receptor, Adenosine triphosphate and Function. The concepts of his Tissue transglutaminase study are interwoven with issues in Cell fate determination, Cellular differentiation, Cell function and Cell biology. His Cancer cell study integrates concerns from other disciplines, such as Cell, Cancer stem cell, Programmed cell death and Protein kinase A.

His most cited work include:

  • Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study (366 citations)
  • Human CD38: a glycoprotein in search of a function (312 citations)
  • Human CD38: a glycoprotein in search of a function (312 citations)

What are the main themes of his work throughout his whole career to date?

Kapil Mehta focuses on Cancer research, Tissue transglutaminase, Biochemistry, Immunology and Retinoic acid. His Cancer research research incorporates elements of Cancer cell, Cancer, Metastasis, Cancer stem cell and Small interfering RNA. His work in Small interfering RNA addresses subjects such as Pancreatic cancer, which are connected to disciplines such as Ectopic expression.

His Tissue transglutaminase research also works with subjects such as

  • Molecular biology and related Molecular mass,
  • Cell biology which connect with Cell growth. His biological study deals with issues like Cell, which deal with fields such as Cell culture. His Retinoic acid study combines topics in areas such as Tumor necrosis factor alpha and Leukemia.

He most often published in these fields:

  • Cancer research (49.74%)
  • Tissue transglutaminase (28.80%)
  • Biochemistry (22.51%)

What were the highlights of his more recent work (between 2007-2020)?

  • Cancer research (49.74%)
  • Cancer (17.28%)
  • Cancer stem cell (13.09%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cancer research, Cancer, Cancer stem cell, Cancer cell and Metastasis. His study in Cancer research is interdisciplinary in nature, drawing from both Protein kinase B, Signal transduction, Small interfering RNA, Inflammation and Tissue transglutaminase. His work in Signal transduction covers topics such as Molecular biology which are related to areas like Twist transcription factor.

The various areas that Kapil Mehta examines in his Tissue transglutaminase study include Internal medicine and Pancreatic cancer. His Cancer research includes themes of Apoptosis, Disease and Chemotherapy. Kapil Mehta focuses mostly in the field of Metastasis, narrowing it down to matters related to Immunology and, in some cases, Cell and Carcinogenesis.

Between 2007 and 2020, his most popular works were:

  • Transglutaminase Regulation of Cell Function (210 citations)
  • Liposome-Encapsulated Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma In vitro and in Xenografts through the Inhibition of Nuclear Factor κB by an AKT-Independent Pathway (152 citations)
  • Designing a broad-spectrum integrative approach for cancer prevention and treatment (144 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Cancer

His primary scientific interests are in Cancer research, Cancer, Protein kinase B, Cell biology and Small interfering RNA. His research in Cancer research intersects with topics in Inflammation, Metastasis and In vivo. His studies in Metastasis integrate themes in fields like Cancer stem cell and Immunology.

His Immunology research is multidisciplinary, incorporating perspectives in Cancer cell and Cell type. His Cancer research is multidisciplinary, relying on both Integrative medicine, Pharmacology and Bioinformatics. His biological study spans a wide range of topics, including Cellular differentiation and Cell growth.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

Gabriel Lopez-Berestein;Victor Fainstein;Roy Hopfer;Kapil Mehta.
The Journal of Infectious Diseases (1985)

517 Citations

ANTIPROLIFERATIVE EFFECT OF CURCUMIN (DIFERULOYLMETHANE) AGAINST HUMAN BREAST TUMOR CELL LINES

Kapil Mehta;Panayotis Pantazis;Theresa McQueen;Bharat B Aggarwal.
Anti-Cancer Drugs (1997)

448 Citations

Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance

Eswaran Devarajan;Aysegul A. Sahin;Jack S. Chen;Raghu R. Krishnamurthy.
Oncogene (2002)

437 Citations

Human CD38: a glycoprotein in search of a function

Fabio Malavasi;Ada Funaro;Stefano Roggero;Alberto Horenstein;Alberto Horenstein.
Immunology Today (1994)

401 Citations

Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin B

G. Lopez-Berestein;R. Mehta;R. L. Hopfer;K. Mills.
The Journal of Infectious Diseases (1983)

374 Citations

Human CD38, a cell-surface protein with multiple functions.

Kapil Mehta;Umar Shahid;Fabio Malavasi.
The FASEB Journal (1996)

351 Citations

Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.

Lan Li;Bilal Ahmed;Kapil Mehta;Razelle Kurzrock.
Molecular Cancer Therapeutics (2007)

345 Citations

Treatment of Systemic Fungal Infections With Liposomal Amphotericin B

Gabriel Lopez-Berestein;Gerald P. Bodey;Victor Fainstein;Michael Keating.
JAMA Internal Medicine (1989)

334 Citations

Human CD38: a (r)evolutionary story of enzymes and receptors.

Silvia Deaglio;Kapil Mehta;Fabio Malavasi.
Leukemia Research (2001)

305 Citations

Transglutaminase Regulation of Cell Function

Richard L. Eckert;Mari T. Kaartinen;Maria Nurminskaya;Alexey M. Belkin.
Physiological Reviews (2014)

284 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kapil Mehta

Fabio Malavasi

Fabio Malavasi

University of Turin

Publications: 75

László Fésüs

László Fésüs

University of Debrecen

Publications: 39

Gabriel Lopez-Berestein

Gabriel Lopez-Berestein

The University of Texas MD Anderson Cancer Center

Publications: 37

Silvia Deaglio

Silvia Deaglio

University of Turin

Publications: 35

Martin Griffin

Martin Griffin

Aston University

Publications: 29

Antonin de Fougerolles

Antonin de Fougerolles

Alnylam Pharmaceuticals (United States)

Publications: 26

Mauro Piacentini

Mauro Piacentini

University of Rome Tor Vergata

Publications: 25

Timothy F. Walseth

Timothy F. Walseth

University of Minnesota

Publications: 24

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 23

Elena Zocchi

Elena Zocchi

University of Genoa

Publications: 23

Hon Cheung Lee

Hon Cheung Lee

National Cheng Kung University Hospital

Publications: 23

Antonio De Flora

Antonio De Flora

University of Genoa

Publications: 22

Santina Bruzzone

Santina Bruzzone

University of Genoa

Publications: 22

Frances E. Lund

Frances E. Lund

University of Alabama at Birmingham

Publications: 20

Peter J. A. Davies

Peter J. A. Davies

Texas A&M University

Publications: 19

Gail V. W. Johnson

Gail V. W. Johnson

University of Rochester

Publications: 19

Something went wrong. Please try again later.